CRIS today
$0.55-$0.04 (-7.02%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $5.60
Key levels
Resistance$1.60
Resistance$0.80
Support$0.33
Latest news & SEC filings
LegalCuris receives Nasdaq delisting determination
SEC FilingCuris Inc filed a report on a major company event (Form 8-K)
All CRIS news →About Curis
Curis is a biotechnology company developing emavusertib, an oral drug that blocks the proteins IRAK4 and FLT3, for blood cancers. It tests the drug alongside BTK inhibitors in patients with lymphoma affecting the brain and spinal cord, and in chronic lymphocytic leukemia. The company licenses emavusertib exclusively from Aurigene and also holds rights to immuno-oncology programs. It operates in the United States.
Based on the company's 10-K filed Mar 24, 2026.
Nasdaq · Healthcare
CURIS INC (CRIS)
What Is the Price Target for CRIS?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is CRIS a Buy or Sell Right Now?
Thesis
- •Revenue growing -13.4% YoY with DECLINING trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CRIS.
Start Free Trial →Is CRIS Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
PEG
Fair Value
$-5.71
0
Moat Score
NONE
3/9
Piotroski Score
-88.1
Altman Z-Score
What Is Smart Money Doing with CRIS?
Insider Signal
NEUTRAL
1 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CRIS Growth Story
Revenue YoY
-13.4%
3yr Revenue CAGR
-2.4%
EPS Growth YoY
91.57%
FCF Growth YoY
N/A%
Revenue Trend
DECLINING
Dark Pool Trades for CRIS
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CRIS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:20:50 | $0.56 | 1,000 | $$557 | SELL |
| 19:18:29 | $0.55 | 3,113 | $$2K | SELL |
| 18:55:52 | $0.55 | 1,000 | $$552 | SELL |
| 18:42:16 | $0.56 | 5,076 | $$3K | BUY |
| 18:28:13 | $0.55 | 1,000 | $$550 | SELL |
5 dark pool trades shown · $$6K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for CURIS INC (CRIS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CRIS — frequently asked questions
What is CRIS stock price today?
CURIS INC (CRIS) is at $0.55, down 7.02% (-$0.04) at the Nov 12, 2026 close.
Why is CRIS stock moving today?
Latest CRIS news — Nov 7, 2026: Curis receives Nasdaq delisting determination · Nov 6, 2026: Curis Inc filed a report on a major company event (Form 8-K)
What do analysts rate CRIS?
Analyst ratings for CRIS: 0 Buy, 3 Hold, 0 Sell — consensus Hold.
Did CRIS beat earnings?
CRIS last reported on Aug 11, 2026: EPS -$4.02 vs -$6.95 expected — a beat of 42.2%.
What is CRIS's P/E ratio?
CRIS trades at a P/E of 0.1 vs a Healthcare average of 18.4.
Does CRIS pay a dividend?
CRIS does not currently pay a dividend.
What are CRIS support and resistance levels?
Support: $0.33. Resistance: $0.80, $1.60, $4.37.
What are insiders doing with CRIS?
Insider activity: NEUTRAL, 1 buys and 0 sells in the last 90 days.
What is the latest news on CRIS?
Nov 7, 2026: Curis receives Nasdaq delisting determination · Nov 6, 2026: Curis Inc filed a report on a major company event (Form 8-K)